Zhejiang Yatai Pharmaceutical Co., Ltd.

002370

CNE100000MM5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
3.43 ^CNY	+0.59%		+4.57%	-20.05%

Apr. 26	Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 29	Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zhejiang Yatai Pharmaceutical Co., Ltd. Omits Final Cash Dividend for 2019

March 16, 2020 at 03:33 pm EDT

Zhejiang Yatai Pharmaceutical Co., Ltd. omitted final cash dividend for 2019.

Latest news about Zhejiang Yatai Pharmaceutical Co., Ltd.

Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Court Orders Bankruptcy Liquidation of Yatai Pharma Unit	23-06-19	MT
Yatai Pharma Unit Creditor Seeks Bankruptcy Liquidation	23-05-18	MT
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Announces Executive Appointments	22-04-18	CI
Yatai Pharmaceutical's Shareholder Plans to Sell 7.27% Stake in the Company	22-01-11	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-26	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. signed a mediation agreement to acquire the remaining 49% stake in Wuhan Optics Valley Yatai Pharmaceutical Co., Ltd. from Hubei Science & Technology Investment Group Corporation Limited.	20-09-14	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-26	CI
Zhejiang Yatai Pharmaceutical Co., Ltd.(XSEC:002370) dropped from S&P Global BMI Index	20-06-22	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Omits Final Cash Dividend for 2019	20-03-16	CI
Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-28	CI

Chart Zhejiang Yatai Pharmaceutical Co., Ltd.

Duration

Period

Chart Zhejiang Yatai Pharmaceutical Co., Ltd.

More charts

Zhejiang Yatai Pharmaceutical Co., Ltd. is a China-based company engaged in the manufacture and distribution of drugs. The Company's main business consists of the research, development, production and sales of chemical agents, chemical raw materials and diagnostic reagents, as well as the provision of pharmaceutical research and development outsourcing (CRO) services. The Companyâs chemical agents are classified as antibiotics and non-antibiotic drugs. Along with its subsidiaries, the Company provides preclinical research services, clinical research services and other advisory services. The Company distributes its products primarily in domestic markets and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG YATAI PHARMACEUTICAL CO., LTD.	-20.05%	289M
ELI LILLY AND COMPANY	+32.36%	695B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.40%	361B
MERCK & CO., INC.	+19.46%	330B
ABBVIE INC.	+3.50%	283B
ASTRAZENECA PLC	+16.34%	239B
NOVARTIS AG	+6.68%	204B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+8.62%	168B

Other Pharmaceuticals